Lupin has informed that, as approved by the Nomination and Remuneration Committee of the Company on December 13, 2023, the Company granted stock options aggregating 258695 to its employees and those of its subsidiaries, at the exercise price of 2.00 each, details of which are enclosed. It has informed that upon vesting, one stock option entitles the grantee to subscribe to one equity share of the Company of ? 2.00 each. The vesting schedule of stock options will be 25%:25%:25%:25% over four years upon completion of one year from the date of grant.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: